Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Ventspils

15 clinical trials in Ventspils, Latvia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Ventspils at a glance
15
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

15 trials in Ventspils

Open in trial search
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Alvotech Swiss AG
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:LatviaLatvia
  • Participants:65+ years
  • Substances:Aflibercept

Endocrine ophthalmopathy

Not yet recruiting
InvestigationalNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
  • Sponsor:Tourmaline Bio Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:4d Molecular Therapeutics Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Curateq Biologics Private Limited
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH

Other cities in Latvia

The busiest research cities in the country

All 19 cities in Latvia

Clinical research in Ventspils

What the registry says about research in the country

01 Ophthalmology Research

Groundbreaking studies focusing on Thyroid Eye Disease (TED) treatments, evaluating innovative therapies aimed at reducing proptosis and improving patient outcomes.

  • Thyroid Eye Disease Management
  • Proptosis Treatment Evaluation
  • Novel Therapeutic Approaches

Multiple trials are investigating both new compounds and maintenance therapies for long-term disease control.

02 Retinal Disorders

Comprehensive research into chorioretinal vascular diseases, including treatments for age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.

  • Wet AMD Treatment
  • Diabetic Eye Complications
  • Advanced Drug Delivery Systems

Studies are evaluating new administration methods and biosimilar treatments for enhanced patient care.

03 Cardiovascular Medicine

Innovative research comparing treatments for stroke prevention in patients with atrial fibrillation, focusing on next-generation anticoagulants.

  • Stroke Prevention
  • Atrial Fibrillation Management
  • Bleeding Risk Assessment

Clinical trials are exploring superior alternatives to existing treatments while maintaining optimal safety profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).